SARS vaccines: where are we? (Q37524036)

20 August 2017

3 references

13 July 2022

22 October 2022

SARS vaccines: where are we? (English)

1 reference

20 August 2017

0 references

Rachel L Roper

1

0 references

author name string

Kristina E Rehm

series ordinal

2

1 reference

20 August 2017

1 July 2009

3 references

Expert Review of Vaccines

20 August 2017

13 July 2022

22 October 2022

3 references

20 August 2017

13 July 2022

22 October 2022

8

1 reference

20 August 2017

7

1 reference

20 August 2017

887-898

1 reference

The Genome sequence of the SARS-associated coronavirus

20 August 2017

1 reference

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

Aetiology: Koch's postulates fulfilled for SARS virus

21 January 2018

1 reference

21 January 2018

1 reference

A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China

21 January 2018

1 reference

SARS-associated coronavirus transmitted from human to pig

21 January 2018

1 reference

Virology: SARS virus infection of cats and ferrets

21 January 2018

1 reference

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China

21 January 2018

1 reference

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

21 January 2018

1 reference

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

21 January 2018

1 reference

A novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

Coronavirus as a possible cause of severe acute respiratory syndrome

21 January 2018

1 reference

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

21 January 2018

1 reference

Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus

21 January 2018

1 reference

Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways

21 January 2018

1 reference

Severe acute respiratory syndrome

21 January 2018

1 reference

Severe acute respiratory syndrome--a new coronavirus from the Chinese dragon's lair.

21 January 2018

1 reference

SARS: clinical virology and pathogenesis

21 January 2018

1 reference

A major outbreak of severe acute respiratory syndrome in Hong Kong

21 January 2018

1 reference

Stability and inactivation of SARS coronavirus

21 January 2018

1 reference

Clinical presentations and outcome of severe acute respiratory syndrome in children.

21 January 2018

1 reference

Identification of antigenic sites mediating antibody-dependent enhancement of feline infectious peritonitis virus infectivity

21 January 2018

1 reference

Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies

21 January 2018

1 reference

Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus

21 January 2018

1 reference

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

21 January 2018

1 reference

CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus

21 January 2018

1 reference

Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development.

21 January 2018

1 reference

SARS corona virus peptides recognized by antibodies in the sera of convalescent cases

21 January 2018

1 reference

Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation

21 January 2018

1 reference

Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein

21 January 2018

1 reference

The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles

21 January 2018

1 reference

The severe acute respiratory syndrome coronavirus 3a is a novel structural protein.

21 January 2018

1 reference

Immunogenicity of SARS inactivated vaccine in BALB/c mice

21 January 2018

1 reference

Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry

21 January 2018

1 reference

A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice.

21 January 2018

1 reference

Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice

21 January 2018

1 reference

Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice.

21 January 2018

1 reference

Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain

21 January 2018

1 reference

SARS vaccine protective in mice

21 January 2018

1 reference

Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV

21 January 2018

1 reference

Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines

21 January 2018

1 reference

Severe acute respiratory syndrome coronavirus infection in vaccinated ferrets

21 January 2018

1 reference

Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys

21 January 2018

1 reference

Severe acute respiratory syndrome coronavirus nucleocapsid protein expressed by an adenovirus vector is phosphorylated and immunogenic in mice.

21 January 2018

1 reference

Recombinant viruses as vaccines and immunological tools

21 January 2018

1 reference

Adenovirus vectors as recombinant viral vaccines

21 January 2018

1 reference

Effects of a SARS-associated coronavirus vaccine in monkeys.

21 January 2018

1 reference

Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1.

21 January 2018

1 reference

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

21 January 2018

1 reference

Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets

21 January 2018

1 reference

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.

21 January 2018

1 reference

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

21 January 2018

1 reference

Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens

21 January 2018

1 reference

SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector

21 January 2018

1 reference

A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies

21 January 2018

1 reference

Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses

21 January 2018

1 reference

Type IVB pilus operon promoter controlling expression of the severe acute respiratory syndrome-associated coronavirus nucleocapsid gene in Salmonella enterica Serovar Typhi elicits full immune response by intranasal vaccination

21 January 2018

1 reference

SARS: lessons learned from other coronaviruses.

21 January 2018

1 reference

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

21 January 2018

1 reference

Severe acute respiratory syndrome (SARS)--paradigm of an emerging viral infection.

21 January 2018

1 reference

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

21 January 2018

1 reference

Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccine.

21 January 2018

1 reference

A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination

21 January 2018

1 reference

Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infection

21 January 2018

1 reference

Cytotoxic T lymphocytes are critical in the control of infectious bronchitis virus in poultry

21 January 2018

1 reference

Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine

21 January 2018

1 reference

Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus

21 January 2018

1 reference

DNA vaccines: immunology, application, and optimization*

21 January 2018

1 reference

Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments.

21 January 2018

1 reference

Optimization of a DNA vaccine against SARS.

21 January 2018

1 reference

Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS.

21 January 2018

1 reference

Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB/c mice.

21 January 2018

1 reference

A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro.

21 January 2018

1 reference

Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine

21 January 2018

1 reference

SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens

21 January 2018

1 reference

Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope

21 January 2018

1 reference

Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models

21 January 2018

1 reference

Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines

21 January 2018

1 reference

A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo

21 January 2018

1 reference

Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice.

21 January 2018

1 reference

A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters

21 January 2018

1 reference

Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines

21 January 2018

1 reference

Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice

21 January 2018

1 reference

Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease

21 January 2018

1 reference

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

21 January 2018

1 reference

Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys.

21 January 2018

1 reference

Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice

21 January 2018

1 reference

Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters

21 January 2018

1 reference

Animal models and vaccines for SARS-CoV infection

21 January 2018

1 reference

Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice

21 January 2018

1 reference

Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus.

21 January 2018

1 reference

Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor

21 January 2018

1 reference

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets

21 January 2018

1 reference

Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets

21 January 2018

1 reference

Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases

21 January 2018

1 reference

Severe acute respiratory syndrome (SARS): a year in review.

21 January 2018

1 reference

Cynomolgus macaque as an animal model for severe acute respiratory syndrome

21 January 2018

1 reference

Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever

21 January 2018

1 reference

Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro.

21 January 2018

1 reference

Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants

21 January 2018

1 reference

Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia.

21 January 2018

1 reference

Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus

21 January 2018

1 reference

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

21 January 2018

1 reference

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.

21 January 2018

1 reference

Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions

21 January 2018

1 reference

Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen

21 January 2018

1 reference

Antibody responses to individual proteins of SARS coronavirus and their neutralization activities

21 January 2018

1 reference

Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus

21 January 2018

1 reference

In the eye of the beholder

21 January 2018

1 reference

Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain

21 January 2018

1 reference

12 December 2020

Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice

1 reference

12 December 2020

SARS: what have we learned?

1 reference

12 December 2020

Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients.

1 reference

12 December 2020

The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host

1 reference

12 December 2020

Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARS coronavirus and stimulates robust immune responses in macaques

1 reference

12 December 2020

SARS coronavirus: a new challenge for prevention and therapy

1 reference

12 December 2020

Recombinant viruses as tools to induce protective cellular immunity against infectious diseases.

1 reference

12 December 2020

Development of subunit vaccines against severe acute respiratory syndrome

1 reference

12 December 2020

Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene

1 reference

12 December 2020

Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine

1 reference

12 December 2020

SARS virus returns to China as scientists race to find effective vaccine

1 reference

12 December 2020

Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine

1 reference

12 December 2020

Large-scale preparation of UV-inactivated SARS coronavirus virions for vaccine antigen

1 reference

12 December 2020

Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus

1 reference

12 December 2020

Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers

1 reference

12 December 2020

Comparative immunization in BALB/c mice with recombinant replication-defective adenovirus vector and DNA plasmid expressing a SARS-CoV nucleocapsid protein gene.

1 reference

12 December 2020

The carboxyl-terminal 120-residue polypeptide of infectious bronchitis virus nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection.

1 reference

12 December 2020

Study of laboratory characteristic of 4 patients with sporadic severe acute respiratory syndrome in 2004

1 reference

12 December 2020

Pathological changes in masked palm civets experimentally infected by severe acute respiratory syndrome (SARS) coronavirus

1 reference

12 December 2020

Surveillance on severe acute respiratory syndrome associated coronavirus in animals at a live animal market of Guangzhou in 2004

1 reference

12 December 2020

Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against

1 reference

12 December 2020

Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses

1 reference

12 December 2020

Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system

1 reference

12 December 2020

Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses

1 reference

12 December 2020

Development of protection against coronavirus induced diseases. A review.

1 reference

12 December 2020

Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection.

1 reference

12 December 2020

Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice

1 reference

12 December 2020

Identifiers

DOI

10.1586/ERV.09.43

1 reference

20 August 2017

0 references

1 reference

PubMed ID

19538115